Sign up to save your podcasts
Or
Share BRIDGE: Predicting Breast Cancer Response from Tumor Composition
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BRIDGE: Predicting Breast Cancer Response from Tumor Composition
BRIDGE predicts pathological complete response to neoadjuvant breast cancer therapy by analyzing intratumoral molecular subtype composition, outperforming existing clinical predictors.
View all episodes
By MedAI DigestBRIDGE predicts pathological complete response to neoadjuvant breast cancer therapy by analyzing intratumoral molecular subtype composition, outperforming existing clinical predictors.